The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 533 KB) and Technical Notes (PDF, 752 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 1.11

Age Distribution (%) of Incidence Cases by Site, 2007-2011
All Races, Both Sexes
Site Ages <20 Ages 20-34 Ages 35-44 Ages 45-54 Ages 55-64 Ages 65-74 Ages 75-84 Ages 85+ All Ages Number of Cases
All Sites 1.0 2.7 5.2 14.1 24.1 25.4 19.6 7.8 100.0% 2,001,481
Oral Cavity & Pharynx: 0.6 2.1 5.6 19.8 29.5 21.9 14.4 6.1 100.0% 48,868
Lip 0.2 1.1 5.4 15.0 18.9 23.9 22.6 12.8 100.0% 2,908
Tongue 0.1 1.9 5.1 19.7 32.7 23.0 12.9 4.7 100.0% 14,368
Salivary gland 2.1 6.4 7.7 14.2 19.8 19.7 19.7 10.5 100.0% 5,494
Floor of mouth 0.0 0.3 3.1 20.0 32.7 25.2 14.1 4.6 100.0% 2,569
Gum & other oral cavity 0.7 2.1 4.6 12.8 22.9 23.7 21.6 11.6 100.0% 6,582
Nasopharynx 3.5 5.9 13.3 24.5 25.5 15.6 9.4 2.3 100.0% 2,866
Tonsil 0.0 0.5 6.1 30.6 38.0 17.0 6.3 1.5 100.0% 8,475
Oropharynx 0.1 0.2 3.9 20.1 34.0 24.7 12.7 4.2 100.0% 1,797
Hypopharynx 0.0 0.2 1.4 16.7 31.8 28.1 17.2 4.5 100.0% 2,835
Other oral cavity & pharynx 0.2 0.8 3.1 16.8 27.8 27.7 15.4 8.1 100.0% 974
Digestive System: 0.2 1.0 3.6 13.5 22.9 24.4 23.1 11.3 100.0% 365,536
Esophagus 0.0 0.3 2.0 11.7 27.1 27.7 22.6 8.5 100.0% 19,290
Stomach 0.1 1.7 4.5 12.2 20.4 24.7 24.3 12.2 100.0% 32,063
Small intestine 0.1 1.4 5.1 15.7 25.4 25.1 19.5 7.6 100.0% 9,263
Colon & Rectum: 0.1 1.2 4.1 14.2 21.2 23.9 23.2 12.1 100.0% 188,874
Colon 0.1 1.0 3.5 11.9 19.7 24.4 25.5 13.9 100.0% 133,670
Rectum 0.1 1.6 5.6 19.9 24.8 22.5 17.7 7.7 100.0% 55,204
Colon & Rectum (Male) 0.1 1.2 4.1 15.0 23.6 25.7 21.5 8.8 100.0% 97,463
Colon & Rectum (Female) 0.1 1.2 4.1 13.4 18.6 22.0 25.1 15.6 100.0% 91,411
Anus, anal canal & anorectum 0.0 1.1 7.3 25.2 27.6 18.7 13.9 6.2 100.0% 7,834
Liver & intrahepatic bile duct 0.9 0.8 2.3 16.8 33.5 22.5 17.1 6.0 100.0% 35,695
Gallbladder 0.0 0.3 2.6 8.6 19.4 25.7 28.5 14.8 100.0% 4,919
Other biliary 0.1 0.5 2.4 8.4 19.8 25.4 28.5 14.8 100.0% 7,960
Pancreas 0.1 0.4 2.1 9.4 21.5 26.3 26.8 13.4 100.0% 52,863
Retroperitoneum 9.0 4.8 7.3 15.3 22.5 21.4 15.2 4.5 100.0% 1,677
Peritoneum, omentum & mesentery 0.4 1.0 2.7 9.7 24.4 33.1 22.9 5.9 100.0% 2,698
Other digestive system 0.3 0.8 2.8 10.8 20.5 23.0 28.1 13.7 100.0% 2,400
Respiratory System: 0.1 0.4 1.4 9.0 21.9 31.3 27.1 8.7 100.0% 274,682
Nose, nasal cavity & middle ear 1.8 4.0 7.3 14.9 23.7 21.4 17.9 8.9 100.0% 2,995
Larynx 0.0 0.4 2.6 15.4 30.8 28.7 17.2 4.9 100.0% 14,687
Lung & bronchus 0.0 0.3 1.3 8.6 21.4 31.7 27.9 8.9 100.0% 256,086
Lung & bronchus (Male) 0.0 0.2 1.2 8.4 22.5 32.2 27.5 8.1 100.0% 135,278
Lung & bronchus (Female) 0.0 0.3 1.4 8.9 20.2 31.0 28.3 9.9 100.0% 120,808
Pleura 5.6 1.6 3.2 10.5 15.3 21.8 27.4 14.5 100.0% 124
Trachea & other respiratory organs 17.7 20.0 9.1 11.3 13.0 12.8 10.9 5.2 100.0% 790
Bones & joints 26.9 15.7 9.3 12.9 12.4 10.1 9.0 3.7 100.0% 3,972
Soft tissue (including heart) 9.0 9.2 9.4 14.7 17.9 16.5 16.0 7.3 100.0% 14,395
Skin (excl. basal & squamous): 0.6 6.2 9.2 16.7 21.4 20.1 17.6 8.1 100.0% 100,797
Melanoma of the skin 0.5 6.2 9.4 17.3 22.0 20.2 16.8 7.4 100.0% 92,417
Other non-epithelial skin 1.3 5.4 6.7 9.7 14.8 19.4 26.2 16.5 100.0% 8,380
Breast (Female) 0.0 1.8 9.3 22.0 25.5 21.3 14.4 5.7 100.0% 292,397
Breast (Female -in situ) 0.0 0.7 10.4 28.5 27.1 20.3 10.8 2.2 100.0% 74,063
Female Genital System: 0.4 4.1 8.9 19.0 27.9 20.6 13.3 5.8 100.0% 115,291
Cervix uteri 0.1 13.8 24.9 24.2 17.6 10.7 5.9 2.7 100.0% 17,223
Corpus uteri 0.0 1.6 5.6 18.4 34.1 23.5 12.5 4.3 100.0% 57,667
Uterus, NOS 0.1 1.7 5.4 15.8 25.4 20.4 16.7 14.6 100.0% 1,644
Ovarya 1.2 3.7 7.2 18.6 23.9 20.7 16.6 8.1 100.0% 29,010
Vagina 0.9 1.8 5.1 13.5 23.9 22.4 20.8 11.6 100.0% 1,759
Vulva 0.2 2.1 6.4 15.1 19.7 19.3 22.5 14.6 100.0% 5,699
Other female genital system 0.9 6.3 6.2 14.6 24.9 23.5 16.8 6.9 100.0% 2,289
Male Genital System: 0.3 1.9 1.5 9.9 31.6 34.9 16.3 3.7 100.0% 311,294
Prostate 0.0 0.0 0.6 9.7 32.7 36.3 16.8 3.8 100.0% 297,322
Testis 6.6 48.9 23.8 13.5 5.0 1.3 0.6 0.2 100.0% 11,801
Penis 0.1 1.7 5.8 11.7 22.9 25.0 22.3 10.5 100.0% 1,663
Other male genital system 3.1 2.8 6.9 13.2 21.5 18.7 21.5 12.4 100.0% 508
Urinary System: 0.6 1.0 3.4 11.0 21.7 26.7 25.0 10.5 100.0% 158,403
Urinary bladder 0.1 0.4 1.5 7.1 18.5 27.9 30.5 14.0 100.0% 86,940
Kidney & renal pelvis 1.2 1.8 6.0 16.4 26.2 25.2 17.4 5.7 100.0% 67,743
Ureter 0.0 0.1 0.6 4.1 14.3 28.7 36.1 16.0 100.0% 2,399
Other urinary system 0.0 0.7 1.7 7.1 17.4 24.6 31.5 17.0 100.0% 1,321
Eye & Orbit 12.9 3.2 6.4 14.9 19.9 20.4 15.7 6.5 100.0% 3,454
Brain & Nervous System: 13.1 8.9 8.4 14.8 19.7 17.0 13.3 4.8 100.0% 27,816
Brain 12.4 8.8 8.2 14.7 20.0 17.4 13.6 5.0 100.0% 26,100
Cranial nerves & other nervous system 23.7 10.4 11.8 15.9 16.0 10.7 8.6 2.9 100.0% 1,716
Endocrine System: 2.9 14.7 19.0 23.7 19.8 12.5 5.9 1.5 100.0% 59,131
Thyroid 1.8 15.1 19.6 24.2 19.9 12.3 5.7 1.4 100.0% 55,834
Other endocrine & thymus 21.7 7.6 8.2 14.5 19.0 16.6 9.8 2.7 100.0% 3,297
Lymphoma: 3.0 7.1 7.2 13.1 19.5 21.4 20.2 8.5 100.0% 96,350
Hodgkin lymphoma 12.8 31.0 14.5 12.7 10.9 9.1 6.6 2.3 100.0% 11,757
Non-Hodgkin lymphoma 1.6 3.8 6.2 13.2 20.7 23.1 22.1 9.3 100.0% 84,593
Myeloma 0.0 0.6 3.1 11.4 23.0 27.7 24.7 9.5 100.0% 26,346
Leukemia: 10.1 4.6 5.0 10.3 17.1 20.6 21.3 11.0 100.0% 55,604
Lymphocytic: 15.2 2.9 3.1 9.2 17.9 21.1 20.3 10.2 100.0% 27,868
Acute lymphocytic 58.8 10.2 5.5 7.0 7.3 5.5 4.2 1.5 100.0% 7,190
Chronic lymphocytic 0.0 0.2 1.6 9.0 21.5 27.2 26.7 13.7 100.0% 18,934
Other lymphocytic 0.2 2.0 10.4 19.3 23.6 18.3 17.8 8.3 100.0% 1,744
Myeloid & Monocytic: 4.9 6.7 7.2 12.0 16.6 20.5 22.0 10.2 100.0% 25,048
Acute myeloid 5.6 6.4 6.3 11.0 16.2 21.3 23.1 10.1 100.0% 16,173
Chronic myeloid 2.7 7.6 9.2 14.2 17.9 18.9 19.5 10.0 100.0% 7,113
Acute monocytic 9.6 5.7 8.4 12.6 17.9 17.0 19.6 9.1 100.0% 1,082
Other myeloid & monocytic 4.0 5.7 6.8 10.9 11.8 22.6 22.6 15.6 100.0% 680
Other leukemia: 4.5 3.5 4.0 7.6 12.5 16.1 26.1 25.7 100.0% 2,688
Other acute leukemia 8.0 4.3 3.5 7.8 10.7 14.8 24.5 26.4 100.0% 1,036
Aleukemic, subleukemic & NOS 2.3 3.0 4.4 7.4 13.6 16.9 27.1 25.3 100.0% 1,652
Kaposi Sarcoma 0.4 20.3 26.5 21.1 9.7 7.7 8.1 6.3 100.0% 2,258
Mesothelioma 0.1 0.7 1.9 6.0 16.1 27.2 33.8 14.3 100.0% 4,267
Ill-defined & unspecified 0.4 0.9 2.4 9.4 18.4 22.2 27.0 19.3 100.0% 38,242

Footnotes:

Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Percents may not sum to 100 due to rounding.

a Ovary excludes borderline cases or histologies 8442, 8451, 8462, 8472, and 8473.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.